Institute News

The International Joint Conference on Artificial Intelligence (IJCAI), one of the world's leading conferences in artificial intelligence, will take place from August 15 to 21, 2026, in Bremen, Germany, jointly with the European Conference on Artificial Intelligence (ECAI). Experts from the Fraunhofer Institute for Digital Medicine MEVIS look forward to welcoming you at our booth in the Congress Centrum Bremen from August 18 to 21 and discussing our latest research in trustworthy and application-oriented artificial intelligence for medical imaging and digital healthcare.

A recent study led by Max de Grauw from the team of Alessa Hering at Radboud University Medical Center investigated the impact of AI support developed by Fraunhofer MEVIS on RECIST assessment in follow-up CT scans of 212 cancer patients. Across 23 readers from 11 institutions, the AI assistance reduced assessment time per patient by about one third compared with manual reading and increased inter-reader agreement of RECIST outcomes by 7.7%.

Fraunhofer MEVIS is participating in the “AI x Open Lab – in Summer of AI,” a program in Bremen focused on artificial intelligence, taking place in summer 2026 alongside the international conference IJCAI-ECAI. With interactive stations for young adults and a public dialogue event, the institute demonstrates how AI opens up new possibilities in healthcare and invites experts from science and medicine, as well as interested members of the public, to discuss these developments together using concrete examples.

On June 29, 2026, the Fraunhofer MEVIS Advisory Board convened in Bremen for its 18th meeting, chaired by Prof. Hans Maier.

As a research and technology transfer institute for digital medicine, Fraunhofer MEVIS—together with the Leibniz Institute for Prevention Research and Epidemiology (BIPS) and the U Bremen Research Alliance (UBRA)—calls for a change of course in its new position paper “AI4Prevention”: away from late, reactive treatment and toward early, precise prevention that spares patients unnecessary or unlikely-to-succeed interventions.

The Fraunhofer Institute for Digital Medicine MEVIS is again well represented at this year’s European Congress on Digital Pathology (ECDP 2026), taking place 17–20 June 2026 in Graz, Austria.

Matthias Günther, Deputy Institute Director of Fraunhofer MEVIS, was designated Fellow of the Society at this year’s meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) held in Cape Town, South Africa from May 9 to 14.

The MS Wissenschaft will launch its tour in Berlin on May 7, 2026, as part of the Science Year 2026 – “Medicine of the Future.” Fraunhofer MEVIS is also on board, presenting, within a joint exhibit by Fraunhofer Health, how artificial intelligence is used in tumour follow up control.

Fraunhofer MEVIS once again participated in Girls’ Day on April 23 with an extensive program on the topic of Digital Medicine. The aim was to arouse the interest of around 20 participating schoolgirls from the 7th grade onwards in scientific content, to convey this in a practical way and to show them perspectives within the STEM subjects.

DMEA 2026, Europe’s leading event for digital health, will take place at Messe Berlin from April 21 to 23. Experts from the fields of healthcare, IT, and research will come together to present and discuss the latest developments, technologies, and solutions for digital transformation in healthcare. Our experts look forward to welcoming you at the joint booth of the Fraunhofer-Gesellschaft (Hall 2.2 | Booth D-109).